You are here: Industry Insights > Gamma Biosciences

News List

Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies PharmaSources.com
September 26, 2021
Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced a strategic investment in Nirrin Technologies...
Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines PharmaSources
May 19, 2021
Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines
Gamma Biosciences to Acquire BioMagnetic Solutions, Adding Novel Immunomagnetic Cell Separation Platform to Bioseparation Portfolio PharmaSources.com
January 18, 2021
MENLO PARK, California, January 15, 2020 – Gamma Biosciences, a life sciences tool platform created by KKR, has agreed to acquire State College, Pennsylvania based, BioMagnetic Solutions (BMS), a next-generation cell selection and bioseparation technology
Gamma Biosciences Announces Strategic Licensing Agreement by Astrea Bioseparations for Advanced Application of Avacta Affimer® Reagent Technology PharmaSources.com
December 21, 2020
MENLO PARK, California and CAMBRIDGE, United Kingdom, December 21, 2020 – Gamma Biosciences, a life sciences tools platform created by KKR, today announced a licensing.